0001127602-21-014705.txt : 20210429 0001127602-21-014705.hdr.sgml : 20210429 20210429171120 ACCESSION NUMBER: 0001127602-21-014705 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210428 FILED AS OF DATE: 20210429 DATE AS OF CHANGE: 20210429 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deschatelets Pascal CENTRAL INDEX KEY: 0001657720 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 21871975 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2021-04-28 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001657720 Deschatelets Pascal C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Chief Scientific Officer Common Stock 2021-04-28 4 M 0 4500 2.67 A 869587 D Stock Option (Right to Buy) 2.67 2021-04-28 4 M 0 4500 0 D 2023-12-05 Common Stock 4500 381499 D This stock option was granted on 12/5/2013 and is fully vested. /s/ David Watson, attorney-in-fact for Pascal Deschatelets 2021-04-28